Increased Aggregation of Human Platelets Produced by Advanced Glycation End Productsin Vitro

This publication has 45 references indexed in Scilit:

• N^ε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction
  Biochemistry, 1996
• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
  Proceedings of the National Academy of Sciences, 1994
• Pathogenesis of acute myocardial infarction. Novel regulatory systems of bioactive substances in the vessel wall.
  Circulation, 1994
• Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
  The Lancet, 1994
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
  Journal of Clinical Investigation, 1993
• Glucose and diabetic vascular disease ¹
  The FASEB Journal, 1992
• Role of Oxidative Stress in Development of Complications in Diabetes
  Diabetes, 1991
• Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.
  Proceedings of the National Academy of Sciences, 1990
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988